Eli Lilly and Co Newsroom

Earnings Miss: Eli Lilly and Company Missed EPS By 31% And Analysts Are Revising Their Forecasts

Simply Wall St18:54

Roche's Antibody Against Alzheimer's Looks the Best Yet -- Barrons.com

Barron's05:31

AbbVie's Deal for Alzheimer's Antibody Raises Curtain for Roche News on Wednesday -- Barrons.com

Barron's05:12

Eli Lilly and Co Options Spot-On: On October 31st, 103.23K Contracts Were Traded, With 345.79K Open Interest

On October 31st ET, $Eli Lilly and Co(LLY.US)$ had active options trading, with a total trading volume of 103.23K options for the day, of which put options accounted for 42.0% of the total

Futu News04:30

Barclays Maintains Overweight on Eli Lilly, Lowers Price Target to $975

Benzinga02:13 · Ratings

Eli Lilly 'Well-Positioned' for Growth Into 2025 Despite Q3 Volatility, UBS Says

MT Newswires01:57

Eli Lilly Earnings Have Wall Street Jittery on Zepbound Sales. What Comes Next. -- Barrons.com

Barron's01:30

Live On CNBC, Stephanie Link Announces Bought More Eli Lilly And Company

Benzinga00:22

Biogen Slips as Morgan Stanley Downgrades on Leqembi Launch

Seeking AlphaOct 31 22:44

Eli Lilly and Company (NYSE:LLY): Among The 10 Best S&P 500 Stocks to Buy According to Hedge Funds

Yahoo FinanceOct 31 22:40

Eli Lilly and Co's non-covalent BTK inhibitor approved in China, hot competition among domestic and foreign pharmaceutical companies for market layout.

The approval of Calquence brings a new option for Chinese MCL patients who have previously received covalent BTK therapy.

lanjinger.comOct 31 21:26

A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $975 to $1,100

Futu NewsOct 31 21:00 · Ratings

Eli Lilly Is Maintained at Buy by B of A Securities

Dow JonesOct 31 20:51 · Ratings

Express News | Elektrofi Inc: Financing Led by Novo Holdings, Others With Participation From Eli Lilly and Company

BreakingsOct 31 20:43

Express News | Elektrofi Inc: Announces Oversubscribed $112.25 Mln Series C Financing

BreakingsOct 31 20:42

Eli Lilly Analyst Ratings

BenzingaOct 31 20:40 · Ratings

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

24/7 Wall St.Oct 31 20:33

Jefferies Adjusts Price Target on Eli Lilly to $994 From $1,113, Maintains Buy Rating

MT NewswiresOct 31 19:30 · Ratings

Express News | Eli Lilly & Co. : Morgan Stanley Cuts Target Price to $1146.00 From $1158.00

BreakingsOct 31 18:28

Nasdaq Tumbles Over 100 Points Ahead Of Big Tech Earnings: Fear & Greed Index Remains In 'Greed' Zone

BenzingaOct 31 18:22